Download HIV Antiretroviral Therapy in Adults

HIV – Antiretroviral Therapy in Adults
By Prof CN Menezes
References:
1.
WHO. Global HIV/AIDS response: epidemic update and health sector
progress towards Universal Access. Progress report 2011. Available at:
http://whqlibdoc.who.int/publications/2011/9789241502986_eng.pdf.
Accessed August 2013.
2.
UNAIDS World AIDS Day Report – Results. 2012. Available at:
http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiolog
y/2012/gr2012/JC2434_WorldAIDSday_results_en.pdf. Accessed August
2013.
3.
Statistics South Africa. Mid year population estimates 2011. Available at:
http://www.statssa.gov.za/Publications/P0302/P03022013.pdf. Accessed
August 2013.
4.
Fanales-Belasio E, et al. HIV virology and pathogenetic mechanisms of
infection: a brief overview. Ann Ist Super Sanita 2010; 46(1):5-14.
5.
Southern African HIV Clinicians Society. Guidelines for Antiretroviral Therapy
in Adults, September 2012. Available at:
http://www.sahivsoc.org/upload/documents/Guidelines%20for%20antiretrovira
l%20treatment%20therapy%20in%20adults,%20September%202012.pdf.
Accessed August 2013.
6.
National Department of Health. The South African Antiretroviral Treatment
Guidelines 2013: Available at:
http://www.sahivsoc.org/upload/documents/2013%20ART%20GuidelinesShort%20Combined%20FINAL%20draft%20guidelines%2014%20March%20
2013.pdf. Accessed August 2013.
7.
Antiretroviral Treatment of Adult HIV Infection: 2012 recommendations of the
International Antiviral Society – USA Panel. Available at:
http://jama.jamanetwork.com/article.aspx?articleid=1221704. Accessed
August 2013.
8.
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for
the use of antiretroviral agents in HIV-1-infected adults and adolescents:
Department of Health and Human Services (DHHS) 2013. Available at:
http://www.guideline.gov/content.aspx?id=43783. Accessed August 2013.
9.
World Health Organization. Consolidated guidelines on the use of
antiretroviral drugs for treating and preventing HIV infection.
Recommendations for a public health approach. June 2013. Available at:
http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf.
Accessed August 2013.
10.
Williams I, et al. British HIV Association guidelines for the treatment of HIV-1positive adults with antiretroviral therapy 2012. HIV Med. 2012; 13: 1-6.
11.
European AIDS Clinical Society Guidelines. 2012. Available at:
http://www.europeanaidsclinicalsociety.org/images/stories/EACSPdf/EacsGuidelines-v6.1-2edition.pdf . Accessed August 2013.
12.
Cohen MS, et al. HPTN 052 Study Team. Prevention of HIV-1 infection with
early antiretroviral therapy. N Engl J Med. 2011; 365(6):493-505.
13.
Schowalter L, Conradie F. Approaches to tenofovir and abacavir drug
shortages in South Africa: a guide for clinicians. SAJHIVMED 2012; 13(2):567.
14.
John MA, et al. Lamivudine-induced red cell aplasia. J Med Microbiol. 2008;
57(8):1032-5.
15.
Falutz J. Therapy insight: shape changes and metabolic complications
associated with HIV and highly active antiretroviral therapy. Nat Clin Pract
Endocrinol Metab 2007; 3(9):651-61.
16.
Kranick SM, Nath A. Neurologic complications of HIV-1 infection and its
treatment in the era of antiretroviral therapy. Continuum (Minneap
Minn). 2012; 18 (6 Infectious Disease):1319-37.
17.
Jones M, Núñez M. Liver toxicity of antiretroviral drugs. Semin Liver Dis.
2012; 32(2):167-76.
18.
Scherzer R, et al. Association of tenofovir exposure with kidney disease risk in
HIV infection. AIDS. 2012; 26(7):867-75.
19.
Armstrong WS. The immune reconstitution inflammatory syndrome: a clinical
update. Curr Infect Dis Rep. 2013; 15(1):39-45.